EPO and acute myeloid leukemia: Effect of treatment doses and gender on erythroid response rates and progression to acute myeloid leukemia estimated through the random intercept logistic regression modeling, after matching patients on propensity score derived from age, endogenous EPO, transfusion dependency, Hb, ferritin, and IPSS score